Printer Friendly

MEDIWARE FORECASTS LOSS FOR DEC. 31 QUARTER

 MEDIWARE FORECASTS LOSS FOR DEC. 31 QUARTER
 MELVILLE, N.Y., Feb. 7 /PRNewswire/ -- Mediware Information Systems,


Inc. (NASDAQ: MEDW; PSE: MIS) anticipates revenue for its second quarter ended Dec. 31, 1991, to be in the range of $2.1 million to $2.2 million with a net loss of about $125,000.
 At a financial community meeting in Boston this morning, the company said anticipated results reflect larger than budgeted sales of hardware versus software coupled with lower than customary margins on its hardware shies.
 The company said it expects to announce final results and file its 10 Q next week.
 Mediware is a provider of UNIX-based clinical information systems for hospitals. It currently offers systems for the hospital blood bank (Hemocare), pharmacy (Digimedics) and surgical suite (Surgiware).
 -0- 2/7/92
 /CONTACT: Thomas Redington of Redington, 203-222-7399, or 212-926-1733, for Mediware Information Systems/
 (MEDW) CO: Mediware Information Systems, Inc. ST: New York IN: HEA SU: ERN PS -- NY003 -- 7657 02/07/92 10:01 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 7, 1992
Words:166
Previous Article:BCP BOARD TO PROPOSE INCREASE IN EQUITY
Next Article:STEVENS AVIATION EXTENDS FRIENDLY CHALLENGE TO SOUTHWEST AIRLINES
Topics:


Related Articles
MEDIWARE SECOND QUARTER RESULTS IN LINE WITH FORECAST
MEDIWARE REPORTS THIRD QUARTER RESULTS AND MANAGEMENT APPOINTMENTS
MEDIWARE REPORTS THIRD QUARTER RESULTS AND MANAGEMENT APPOINTMENTS
AMSERV HEALTHCARE REPORTS SECOND QUARTER RESULTS
Mediware Forecasts Second Quarter Results
Mediware Posts Second Quarter FY 1999 Results.
Mediware Reports Strong First Quarter.
Mediware Continues Strong Growth in Second Quarter; Software License Revenue Rose 57 Percent; Company on Track to Meet Fiscal-Year Forecast.
Bon Secours Health Systems Licenses Mediware's WORx(TM) Drug Therapy Management System.
Mediware's Transfusion Management Software Adopted by Four Additional Tenet Hospitals.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters